- Home
- BLKB vs OCUL Comparison
BLKB vs OCUL Comparison
Compare BLKB & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLKB | OCUL |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BLKB | OCUL |
|---|---|---|
| Price | $38.37 | $8.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $60.00 | $23.56 |
| AVG Volume (30 Days) | 524.7K | ★ 3.4M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | N/A |
| EPS | ★ 2.37 | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $6.26 | $7.93 |
| Revenue Next Year | $4.25 | $96.07 |
| P/E Ratio | $15.14 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $33.95 | $6.23 |
| 52 Week High | $74.86 | $16.44 |
Technical Indicators
Market Signals| Indicator | BLKB | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 52.06 |
| Support Level | N/A | $8.36 |
| Resistance Level | $40.60 | $12.63 |
| Average True Range (ATR) | 1.83 | 0.58 |
| MACD | 0.18 | 0.13 |
| Stochastic Oscillator | 65.41 | 72.20 |
Price Performance
Historical ComparisonAbout BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.